Top Markets
#1 Bitway Bitway +45.76%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +40.87%
#3 Pons Pons +38.23%
#4 Mubarak Mubarak +35.71%
#5 Ocean Protocol Ocean Protocol +28.63%
#6 Starpower Starpower +28.28%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.26%
#8 SkyAI SkyAI +23.08%
#9 Bio Protocol Bio Protocol +19.68%
#10 Decred Decred +19.01%
Coin of the day
Bitway Bitway
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Rangering i aksjer #29359
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Aksjekurs
$0.365
Sist synkronisert: 2025-08-01
Markedsverdi
$21.54M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Elevation Oncology, Inc. (ELEV)

Kategori

Healthcare
Utbytteavkastning for Elevation Oncology, Inc. (ELEV)
Elevation Oncology, Inc. (aksjesymbol: ELEV) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Elevation Oncology, Inc. (ELEV) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH